Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial

Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for BI 695500 versus rituximab in low-tumor-burden follicular lymphoma is displayed, including study design, participant criteria, locations, and outcome measures.
    Difference
    57%
    Check dated 2026-11-08T15:19:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:29:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study record page continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-25T15:41:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:17:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:20:18.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The Study Record page now shows a 403 Forbidden error, replacing the detailed study information with a minimal error screen and hiding most of the usual content and links.
    Difference
    18%
    Check dated 2026-09-20T22:31:19.000Z thumbnail image

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.